KZ9-17525-58926

4 vaccinations 9 coded responses 30 check-ins 8 free-text entries 4 call cases

Sex: Female
Age at first dose: 46-50
ZIP prefix: 750 / TX
Registered: 2021-03-09

Relationship: Self
Race: White
Ethnicity: Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-09
Registered in v-safe
2021-03-09
Dose 1 — Pfizer-BioNTech
2021-03-09
Survey response — day 0, dose 1
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Joint pains

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness, Abdominal pain

Adult check-in
2021-03-11
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea

Adult check-in
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-03-13
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain

Adult check-in
2021-03-14
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain

Adult check-in
2021-03-16
Health check-in — day 7, dose 1
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain

Adult check-in
2021-03-23
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-30
Dose 2 — Pfizer-BioNTech
2021-03-30
Health check-in — day 0, dose 2
Feeling: Fair · Rash, not including the immediate area around the injection site

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-04-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-06
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-13
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-04-20
Survey response — day 21, dose 2
MedDRA: Depression, Dizziness, Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Dizziness, for two days Extremely tired.Severe Depression for 2 weeks after I received the 2nd dose.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-05-04
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-11
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-29
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-09-28
Survey response — 6 months, dose 2
MedDRA: Migraine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Migraine

MedDRA releases: 2024-11 · check-in free text available
2021-09-28
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2021-09-29
Call 2 — Left Voicemail
2021-10-09
Dose 3 — Pfizer-BioNTech
2022-03-30
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-04-11
Survey response — 6 months, dose 3
MedDRA: Migraine, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Migraine · Healthcare visit (other): In person doctor appointment

MedDRA releases: 2024-11 · check-in free text available
2022-04-11
Report sent to call center — 6 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2022-04-13
Call 2 — Left Voicemail
2022-09-09
Dose 4 — Pfizer-BioNTech
2022-10-09
Survey response — 12 months, dose 3
MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Migraines, and severe migraine

MedDRA releases: 2024-11 · check-in free text available
2022-10-09
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-10-11
Call 3 — Left Voicemail
2022-10-11
Call 3 — Left Voicemail
2022-10-11
Call 2 — Left Voicemail
2022-10-16
Survey response — day 35, dose 4
MedDRA: Pre-existing disease, Viral upper respiratory tract infection — Feeling: Fair · Be unable to do your normal daily activities

Free text: Viral upper respiratory infection and severe allergies

MedDRA releases: 2024-11 · check-in free text available
2022-10-21
Survey response — day 42, dose 4
MedDRA: Viral infection — Feeling: Good · Be unable to do your normal daily activities

Free text: Upper viran infection

MedDRA releases: 2024-11 · check-in free text available
2022-12-13
Survey response — 3 months, dose 4
MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Migraine

MedDRA releases: 2024-11 · check-in free text available
2023-03-12
Survey response — 6 months, dose 4
MedDRA: Colitis, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11
2023-03-12
Report sent to call center — 6 months, dose 4
Get care from a doctor or other healthcare professional

1 call case(s)
2023-03-13
Call 1 — Requested Callback
2023-03-13
Call 1 — Requested Callback
2023-03-13
Call 1 — Requested Callback
2023-03-13
Call 1 — Requested Callback
2023-03-21
Callback requested for
11:00AM ET
2023-03-21
Call successful
Does not wish to fill out VAERS report
2023-03-21
Call successful
Does not wish to fill out VAERS report
2023-03-21
Call successful
Completed over the phone
2023-03-21
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-09	Pfizer-BioNTech
2	2021-03-30	Pfizer-BioNTech
3	2021-10-09	Pfizer-BioNTech	No
4	2022-09-09	Pfizer-BioNTech	No

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 5 — day 0, dose 1

2021-03-09

Systemic reaction (other): Dizziness

Release 7 — day 21, dose 2

2021-04-20

Symptoms: Dizziness, for two days Extremely tired.Severe Depression for 2 weeks after I received the 2nd dose.

Release 9 — 6 months, dose 2

2021-09-28

Symptoms: Migraine

Release 11 — 6 months, dose 3

2022-04-11

Symptoms: Migraine

Healthcare visit (other): In person doctor appointment

Release 12 — 12 months, dose 3

2022-10-09

Symptoms: Migraines, and severe migraine

Release 12 — day 35, dose 4

2022-10-16

Symptoms: Viral upper respiratory infection and severe allergies

Release 12 — day 42, dose 4

2022-10-21

Symptoms: Upper viran infection

Release 12 — 3 months, dose 4

2022-12-13

Symptoms: Migraine

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Colitis	·	·	✓
SD	Depression	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Migraine	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Viral infection	·	·	✓
SD	Viral upper respiratory tract infection	·	·	✓
SRO	Dizziness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release